Clinical Trial Update: Tocilizumab (RoActemra) and Tranexamic Acid (Cyklokapron) Used as Adjuncts to Chronic Subdural Hematoma Surgery [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating tocilizumab and tranexamic acid as adjuncts to chronic subdural hematoma surgery; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)
• Tocilizumab (tocilizumab)

Snippet

Sponsor: Oslo University Hospital | Conditions: Chronic Subdural Hematoma | Phase 2, Phase 3 | Status: TERMINATED